Valeant's Dermatology Sales Strategy: Teenage Zits

Valeant Pharmaceutical International Inc.'s dermatology business is in trouble. But CEO Joseph Papa said the company is counting on teenagers eager to have clear skin when they return to school in the fall to boost prescriptions of the firm's acne medicine Solodyn (minocycline).

More from Dermatological

More from Therapy Areas